BioCentury | Feb 10, 2021
Finance

Notch’s $85M series A builds on Allogene deal for off-the-shelf, iPSC-derived cell therapies

...lines.Founded in 2018, Notch was incubated with assistance from Toronto Innovation Acceleration Partners and the Centre for Commercialization of Regenerative Medicine. The...
BioCentury | Jan 10, 2020
Emerging Company Profile

Empirica: Building a new model for brain cancer

...collaborators: University of Toronto Corporate partners: Centre for Commercialization of Antibody and Biologics (CCAB) and Centre for Commercialization of Regenerative Medicine...
BioCentury | Nov 6, 2019
Company News

Allogene sets sights on iPS cell-based allogeneic therapies via Notch partnership

...at the university. Toronto Innovation Acceleration Partners also helped found the company, as did the Centre for Commercialization of Regenerative Medicine...
BioCentury | Dec 22, 2016
Finance

Starting up stem cells

...capabilities,” said Davis. To create its own manufacturing platform, BlueRock has teamed up with the Centre for Commercialization of Regenerative Medicine...
...Bayer AG (Xetra:BAYN), Leverkusen, Germany BlueRock Therapeutics, Toronto, Ontario Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Centre for Commercialization of Regenerative Medicine...
BioCentury | Feb 19, 2016
Financial News

Atlas backs newco Avrobio

...the company intends to raise a series A round this year. Avrobio also granted the Centre for Commercialization of Regenerative Medicine...
BioCentury | Jan 18, 2016
Company News

General Electric, Federal Economic Development Agency for Southern Ontario, CCRM biomanufacturing, gene/cell therapy news

...Co. (NYSE:GE), Fairfield, Conn. Federal Economic Development Agency for Southern Ontario (FedDev Ontario), Waterloo, Ontario Centre for Commercialization of Regenerative Medicine...
BioCentury | Sep 25, 2014
Strategy

Canadian accelerant

...the Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development , the Centre for Commercialization of Regenerative Medicine...
...BDC Venture Capital , Montreal, Quebec, Canada CDRD Ventures Inc. , Vancouver, British Columbia, Canada Centre for Commercialization of Regenerative Medicine...
BioCentury | Jun 10, 2013
Company News

Cell Therapy Catapult, Centre for Commercialization of Regenerative Medicine (CCRM) deal

...to move early stage cell therapy research to commercialization. Cell Therapy Catapult , London, U.K. Centre for Commercialization of Regenerative Medicine...
BioCentury | Dec 10, 2012
Company News

VistaGen, Centre for Commercialization of Regenerative Medicine (CCRM) gene/cell therapy news

...pluripotent stem cells (see BioCentury, April 23). VistaGen Therapeutics Inc. (OTCBB:VSTA), South San Francisco, Calif. Centre for Commercialization of Regenerative Medicine...
BioCentury | May 7, 2012
Company News

Pfizer, Centre for Commercialization of Regenerative Medicine (CCRM) gene/cell therapy news

...CCRM will contribute matching funds to any approved projects. Pfizer Inc. (NYSE:PFE), New York, N.Y. Centre for Commercialization of Regenerative Medicine...
Items per page:
1 - 10 of 10
BioCentury | Feb 10, 2021
Finance

Notch’s $85M series A builds on Allogene deal for off-the-shelf, iPSC-derived cell therapies

...lines.Founded in 2018, Notch was incubated with assistance from Toronto Innovation Acceleration Partners and the Centre for Commercialization of Regenerative Medicine. The...
BioCentury | Jan 10, 2020
Emerging Company Profile

Empirica: Building a new model for brain cancer

...collaborators: University of Toronto Corporate partners: Centre for Commercialization of Antibody and Biologics (CCAB) and Centre for Commercialization of Regenerative Medicine...
BioCentury | Nov 6, 2019
Company News

Allogene sets sights on iPS cell-based allogeneic therapies via Notch partnership

...at the university. Toronto Innovation Acceleration Partners also helped found the company, as did the Centre for Commercialization of Regenerative Medicine...
BioCentury | Dec 22, 2016
Finance

Starting up stem cells

...capabilities,” said Davis. To create its own manufacturing platform, BlueRock has teamed up with the Centre for Commercialization of Regenerative Medicine...
...Bayer AG (Xetra:BAYN), Leverkusen, Germany BlueRock Therapeutics, Toronto, Ontario Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Centre for Commercialization of Regenerative Medicine...
BioCentury | Feb 19, 2016
Financial News

Atlas backs newco Avrobio

...the company intends to raise a series A round this year. Avrobio also granted the Centre for Commercialization of Regenerative Medicine...
BioCentury | Jan 18, 2016
Company News

General Electric, Federal Economic Development Agency for Southern Ontario, CCRM biomanufacturing, gene/cell therapy news

...Co. (NYSE:GE), Fairfield, Conn. Federal Economic Development Agency for Southern Ontario (FedDev Ontario), Waterloo, Ontario Centre for Commercialization of Regenerative Medicine...
BioCentury | Sep 25, 2014
Strategy

Canadian accelerant

...the Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development , the Centre for Commercialization of Regenerative Medicine...
...BDC Venture Capital , Montreal, Quebec, Canada CDRD Ventures Inc. , Vancouver, British Columbia, Canada Centre for Commercialization of Regenerative Medicine...
BioCentury | Jun 10, 2013
Company News

Cell Therapy Catapult, Centre for Commercialization of Regenerative Medicine (CCRM) deal

...to move early stage cell therapy research to commercialization. Cell Therapy Catapult , London, U.K. Centre for Commercialization of Regenerative Medicine...
BioCentury | Dec 10, 2012
Company News

VistaGen, Centre for Commercialization of Regenerative Medicine (CCRM) gene/cell therapy news

...pluripotent stem cells (see BioCentury, April 23). VistaGen Therapeutics Inc. (OTCBB:VSTA), South San Francisco, Calif. Centre for Commercialization of Regenerative Medicine...
BioCentury | May 7, 2012
Company News

Pfizer, Centre for Commercialization of Regenerative Medicine (CCRM) gene/cell therapy news

...CCRM will contribute matching funds to any approved projects. Pfizer Inc. (NYSE:PFE), New York, N.Y. Centre for Commercialization of Regenerative Medicine...
Items per page:
1 - 10 of 10